Ca2-Dependent Rapid Ca2 Sensitization of Contraction in Arterial Smooth Muscle
暂无分享,去创建一个
Masumi Eto | Toshio Kitazawa | S. Semba | M. Eto | G. Dimopoulos | George J Dimopoulos | Shingo Semba | Kazuyo Kitazawa | Toshio Kitazawa | K. Kitazawa
[1] Toshio Kitazawa,et al. Phosphorylation of the myosin phosphatase targeting subunit and CPI‐17 during Ca2+ Sensitization in Rabbit Smooth Muscle , 2003, The Journal of physiology.
[2] T. Tamaoki,et al. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. , 1989, Biochemical and biophysical research communications.
[3] P. Cullen,et al. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Berridge,et al. Capacitative calcium entry. , 1995, The Biochemical journal.
[5] J. Stull,et al. Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Wier,et al. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. , 2003, Reviews of physiology, biochemistry and pharmacology.
[7] C. Lajoie,et al. In situ determination of [Ca2+]i threshold for translocation of the alpha-protein kinase C isoform. , 1994, The American journal of physiology.
[8] R. A. Murphy,et al. Ca2+, crossbridge phosphorylation, and contraction. , 1989, Annual review of physiology.
[9] D. Brautigan,et al. Defining the Structural Determinants and a Potential Mechanism for Inhibition of Myosin Phosphatase by the Protein Kinase C-potentiated Inhibitor Protein of 17 kDa* , 2001, The Journal of Biological Chemistry.
[10] H. Coste,et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.
[11] M. Ikebe,et al. Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. , 2003, The Biochemical journal.
[12] Toshio Kitazawa,et al. Histamine-induced Vasoconstriction Involves Phosphorylation of a Specific Inhibitor Protein for Myosin Phosphatase by Protein Kinase C α and δ Isoforms* , 2001, The Journal of Biological Chemistry.
[13] D. Hartshorne,et al. Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: Inhibitory effects and occurrence in A7r5 cells , 2005, FEBS letters.
[14] N. Sugimoto,et al. Ca 2-Dependent Activation of Rho and Rho Kinase in Membrane Depolarization – Induced and Receptor Stimulation – Induced Vascular Smooth Muscle Contraction , 2003 .
[15] Toshio Kitazawa,et al. Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle , 1990, Pflügers Archiv.
[16] Shuh Narumiya,et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.
[17] Wen Su,et al. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. , 2005, American journal of physiology. Cell physiology.
[18] K. Gueth,et al. Perfusion cuvette for the simultaneous measurement of mechanical, optical and energetic parameters of skinned muscle fibres , 1986, Pflügers Archiv.
[19] Toshio Kitazawa,et al. A novel mechanism for the Ca(2+)-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase , 1994, The Journal of general physiology.
[20] G. Meissner,et al. Ryanodine activation and inhibition of the Ca2+ release channel of sarcoplasmic reticulum. , 1986, The Journal of biological chemistry.
[21] Masaaki Ito,et al. Myosin light chain phosphatase: subunit composition, interactions and regulation , 1998, Journal of Muscle Research & Cell Motility.
[22] Toshio Kitazawa,et al. Expression of CPI‐17 and myosin phosphatase correlates with Ca2+ sensitivity of protein kinase C‐induced contraction in rabbit smooth muscle , 2001, The Journal of physiology.
[23] M. Elovitz,et al. The effects of 2-aminoethoxydiphenyl borate, a novel inositol 1,4, 5-trisphosphate receptor modulator on myometrial contractions. , 1999, Biochemical and biophysical research communications.
[24] S. Baylor,et al. Myoplasmic binding of fura-2 investigated by steady-state fluorescence and absorbance measurements. , 1988, Biophysical journal.
[25] Toshio Kitazawa,et al. G-protein-mediated Ca2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. , 1991, The Journal of biological chemistry.
[26] Toshio Kitazawa,et al. Agonists Trigger G Protein-mediated Activation of the CPI-17 Inhibitor Phosphoprotein of Myosin Light Chain Phosphatase to Enhance Vascular Smooth Muscle Contractility* , 2000, The Journal of Biological Chemistry.
[27] N. Sugimoto,et al. Ca2+-Dependent Activation of Rho and Rho Kinase in Membrane Depolarization–Induced and Receptor Stimulation–Induced Vascular Smooth Muscle Contraction , 2003, Circulation research.
[28] A. Somlyo,et al. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.
[29] Fast and slowly inactivating components of Ca-channel current and their sensitivities to nicardipine in isolated smooth muscle cells from rat vas deferens , 1988, Pflügers Archiv.
[30] Toshio Kitazawa,et al. Cytosolic heparin inhibits muscarinic and alpha-adrenergic Ca2+ release in smooth muscle. Physiological role of inositol 1,4,5-trisphosphate in pharmacomechanical coupling. , 1989, The Journal of biological chemistry.
[31] D. Hartshorne,et al. Inhibitory Phosphorylation Site for Rho-associated Kinase on Smooth Muscle Myosin Phosphatase* , 1999, The Journal of Biological Chemistry.
[32] Toshio Kitazawa,et al. CPI‐17‐deficient smooth muscle of chicken , 2004, The Journal of physiology.
[33] H. Hidaka,et al. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. , 2002, Pharmacology & therapeutics.